Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$99,100,118
-$3,119,586 QoQ
Shares Held
199,505
-12.8% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#115
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. VRTX ranks #3 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,100,118 | 199,505 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $102,219,704 | 228,915 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $102,138,381 | 225,292 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $68,367,419 | 174,567 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $78,532,389 | 176,398 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $96,133,503 | 198,287 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $104,147,079 | 258,622 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $144,782,659 | 311,307 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $153,867,183 | 328,271 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $162,433,669 | 388,588 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $139,191,372 | 342,086 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $133,647,261 | 384,331 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $139,554,133 | 396,562 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $123,163,383 | 390,908 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $135,479,693 | 469,145 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $140,293,422 | 484,539 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $131,844,750 | 467,883 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $123,765,805 | 474,253 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $141,561,187 | 644,632 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $107,533,251 | 592,829 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $162,890,222 | 807,867 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $167,516,639 | 779,546 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $184,236,246 | 779,539 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $151,878,607 | 558,131 | Shares | Other | 2020-10-19 | |
| 2020-06-30 | $158,564,708 | 546,191 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $172,599,649 | 725,361 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||